-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
NewAmsterdam Pharma Co N.V. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2023 to Q2 2024.
- NewAmsterdam Pharma Co N.V. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $8.29M, a 49.2% increase year-over-year.
- NewAmsterdam Pharma Co N.V. annual Share-based Payment Arrangement, Expense for 2023 was $24.6M, a 488% increase from 2022.
- NewAmsterdam Pharma Co N.V. annual Share-based Payment Arrangement, Expense for 2022 was $4.18M, a 245% increase from 2021.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)